Walmark's net debt reached CZK 1,089 mil and accounted for -773% of equity at the end of 2017. The ratio is down 45.6% when compared to the previous year.
Historically, the firm’s net debt to equity reached an all time high of 195% in 2012 and an all time low of -1,526% in 2015.
When compared to EBITDA, net debt amounted to 7.44x at the end of the year. The ratio reached an all time high of 8.58 in 2008 and an all time low of -35.5 in 2016.
As far as Walmark's peers are concerned, Bayer Czech Republic posted net debt to equity of 94.4%x and 2.49x when compared to EBITDA at the end of 2017. Amgen Czech Republic ended the year 2017 with a net debt at -0.147%x of equity and -0.006x when compared to its EBITDA while Amgen Czech Republic had net debt at -0.147%x of equity and -0.006x to EBITDA at the end of the year.
|Amgen Czech Republic||...||...||-0.005||0.709||1.53|
|Bayer Czech Republic||-0.298||-0.098||0.140||0.150||0.890|
|GlaxoSmithKline Czech Republic||0.438||1.02||1.69||-0.001||-3.71|
|Merck Czech Republic||1.87||1.39||2.80||0.353||-0.026|
|Novartis Czech Republic||3.22||0.696||-0.064||0.826||-0.015|
|Pfizer Czech Republic||2.16||-1.32||-0.141||-1.65||-0.037|
|Roche Czech Republic||-0.002||0.737||0.867||2.04||3.15||...|
|Sanofi-Aventis Czech Republic||12.8||16.5||8.87||27.7||4.27|
|Servier Czech Republic||...||...||-1.54||-2.09||-1.74||-0.839|